Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: AAER

AZ, Amgen file first-in-class asthma drug with the FDA

FDA, News, Regulations

AZ, Amgen file first-in-class asthma drug with the FDA

May 11, 2021

Via: PMLiVE

AZ and Amgen are seeking approval for tezepelumab for the treatment of severe asthma patients, based on results from the companies’ PATHFINDER clinical programme. This includes data from the pivotal phase 3 NAVIGATOR trial, which demonstrated that tezepelumab achieved a […]